BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17189539)

  • 21. p27Kip1 localization depends on the tumor suppressor protein tuberin.
    Rosner M; Freilinger A; Hanneder M; Fujita N; Lubec G; Tsuruo T; Hengstschläger M
    Hum Mol Genet; 2007 Jul; 16(13):1541-56. PubMed ID: 17470459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle.
    Jiang H; Chang FC; Ross AE; Lee J; Nakayama K; Nakayama K; Desiderio S
    Mol Cell; 2005 Jun; 18(6):699-709. PubMed ID: 15949444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase Skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium.
    Lahav-Baratz S; Ben-Izhak O; Sabo E; Ben-Eliezer S; Lavie O; Ishai D; Ciechanover A; Dirnfeld M
    Mol Hum Reprod; 2004 Aug; 10(8):567-72. PubMed ID: 15220466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rho/ROCK signaling in regulation of corneal epithelial cell cycle progression.
    Chen J; Guerriero E; Lathrop K; SundarRaj N
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):175-83. PubMed ID: 18172090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma.
    Kudo Y; Kitajima S; Ogawa I; Miyauchi M; Takata T
    Oral Oncol; 2005 Feb; 41(2):105-16. PubMed ID: 15695111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells.
    Lee JG; Kay EP
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):189-96. PubMed ID: 18172092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.
    Shiraso S; Katayose Y; Yamamoto K; Mizuma M; Yabuuchi S; Oda A; Rikiyama T; Onogawa T; Yoshida H; Hayashi H; Ohtsuka H; Motoi F; Egawa S; Kato J; Unno M
    Anticancer Res; 2009 Jun; 29(6):2015-24. PubMed ID: 19528460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.
    Hershko DD
    Cancer; 2008 Apr; 112(7):1415-24. PubMed ID: 18260093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Damage-specific DNA binding protein 1 (DDB1) is involved in ubiquitin-mediated proteolysis of p27Kip1 in response to UV irradiation.
    Iovine B; Iannella ML; Bevilacqua MA
    Biochimie; 2011 May; 93(5):867-75. PubMed ID: 21237244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons.
    Akashiba H; Matsuki N; Nishiyama N
    J Neurochem; 2006 Nov; 99(3):733-44. PubMed ID: 16824045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium.
    Lecanda J; Parekh TV; Gama P; Lin K; Liarski V; Uretsky S; Mittal K; Gold LI
    Cancer Res; 2007 Feb; 67(3):1007-18. PubMed ID: 17283133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of nuclear Prointerleukin-16 and p27(Kip1) in primary human T lymphocytes.
    Wilson KC; Cattel DJ; Wan Z; Rahangdale S; Ren F; Kornfeld H; Sullivan BA; Cruikshank WW; Center DM
    Cell Immunol; 2005 Sep; 237(1):17-27. PubMed ID: 16289056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of p27(KIP1) and cell proliferation in human retina and retinoblastoma.
    Kase S; Yoshida K; Ohgami K; Shiratori K; Harada T; Ohno S
    Anticancer Res; 2005; 25(6B):3843-6. PubMed ID: 16309169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p27(Kip1) signaling: Transcriptional and post-translational regulation.
    Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
    Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation.
    Sarmento LM; Huang H; Limon A; Gordon W; Fernandes J; Tavares MJ; Miele L; Cardoso AA; Classon M; Carlesso N
    J Exp Med; 2005 Jul; 202(1):157-68. PubMed ID: 15998794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
    Kaproth-Joslin KA; Li X; Reks SE; Kelley GG
    Biochem J; 2008 Nov; 415(3):439-48. PubMed ID: 18588506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive ubiquitination and degradation of c-myb by the 26S proteasome during proliferation and differentiation of myeloid cells.
    Feiková S; Wolff L; Bies J
    Neoplasma; 2000; 47(4):212-8. PubMed ID: 11043824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition.
    Nickeleit I; Zender S; Sasse F; Geffers R; Brandes G; Sörensen I; Steinmetz H; Kubicka S; Carlomagno T; Menche D; Gütgemann I; Buer J; Gossler A; Manns MP; Kalesse M; Frank R; Malek NP
    Cancer Cell; 2008 Jul; 14(1):23-35. PubMed ID: 18598941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.